BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10566613)

  • 41. Immunotherapy of lung cancer. II. Review of clinical trials in small cell carcinoma.
    Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
    Cancer Treat Rev; 1979 Jun; 6(2):125-30. PubMed ID: 226262
    [No Abstract]   [Full Text] [Related]  

  • 42. Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism?
    Board RE; Thatcher N; Lorigan P
    Drugs; 2006; 66(15):1919-31. PubMed ID: 17100404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of small cell lung cancer.
    Rosti G; De Giorgi U; Giovanis P; Cariello A; Dazzi C; Marangolo M
    Monaldi Arch Chest Dis; 1999 Oct; 54(5):427-34. PubMed ID: 10741104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of extracellular matrix in small-cell lung cancer.
    Rintoul RC; Sethi T
    Lancet Oncol; 2001 Jul; 2(7):437-42. PubMed ID: 11905738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal residual disease: detection, clinical relevance, and treatment strategies.
    Dwenger A; Lindemann A; Mertelsmann R
    J Hematother; 1996 Oct; 5(5):537-48. PubMed ID: 8938526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An overview of lung cancer.
    Sachs S; Fiore JJ
    Respir Care Clin N Am; 2003 Mar; 9(1):1-25. PubMed ID: 12820710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Micrometastases and transplantation.
    Sharp JG
    J Hematother; 1996 Oct; 5(5):519-24. PubMed ID: 8938524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
    Krug LM; Grant SC; Miller VA; Ng KK; Kris MG
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):55-61. PubMed ID: 10566613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting lethal minimal residual disease in small cell lung cancer.
    Patel JD; Krug LM; Azzoli CG; Gomez J; Kris MG; Miller VA
    Semin Oncol; 2003 Feb; 30(1):79-85. PubMed ID: 12635092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.
    Shepherd FA
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):30-7. PubMed ID: 11479895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autologous bone marrow transplantation for the treatment of lung cancer.
    Lazarus HM
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):72-9. PubMed ID: 8211219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in management of small-cell lung cancer.
    Chua YJ; Steer C; Yip D
    Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.